|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02615 BIOKIN
Nominal 
() | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 3,841,817 | (617,987) | (256,640) |
| Net Cash from / (used in) Investing Activities | -- | (2,348,591) | (79,399) | (36,977) |
| Net Cash from / (used in) Financing Activities | -- | 1,273,891 | 91,003 | 1,139,833 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 2,767,117 | (606,383) | 846,216 |
| Cash & Cash Equivalents at beginning of period | -- | 391,693 | 1,000,695 | 154,222 |
| Effect of Foreign Exchange Rate Changes | -- | 49,188 | (2,619) | 257 |
| Others | -- | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 3,207,998 | 391,693 | 1,000,695 |
| Remarks: | Real time quote last updated: 02/12/2025 17:55 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -1,117,952 |
| %Change | -- |
| EPS / (LPS) | RMB -2.790 |
| NBV Per Share (¥) | RMB -- |